Biotech revenue hits NT$830.1 billion, but health startup deals and funding both fall
經濟日報 · 2026-10-07
Deloitte Taiwan's Chen Chung-cheng said Taiwan's biotech revenue reached NT$830.1 billion in 2025, up 7.05%, yet health startups closed 126 deals worth US$660 million, down 11% in count and 16% in value. The median age of funded firms rose to 5–6 years as AI and chips draw capital away, so startups must plan commercialization earlier.
Read source ↗